伊曲康唑在肺泡巨噬细胞中的摄取。
Uptake of itraconazole by alveolar macrophages.
作者信息
Perfect J R, Savani D V, Durack D T
机构信息
Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710.
出版信息
Antimicrob Agents Chemother. 1993 Apr;37(4):903-4. doi: 10.1128/AAC.37.4.903.
Abstract
Itraconazole is a broad-spectrum potent triazole antifungal agent. Its efficacy in treatment cannot always be explained by body fluid drug levels. In this study, itraconazole was shown to accumulate into host cells. Its intracellular accumulation in cells is greater than that of the antibacterial agent clindamycin, which is known for intracellular localization, and the uptake process does not appear to be active. This ability to reach high concentrations intracellularly may be an important property for the in vivo efficacy of itraconazole.
摘要
伊曲康唑是一种广谱强效三唑类抗真菌药。其治疗效果并不总能通过体液药物水平来解释。在本研究中，伊曲康唑被证明可在宿主细胞中蓄积。其在细胞内的蓄积量大于以细胞内定位而闻名的抗菌药物克林霉素，且摄取过程似乎并非主动摄取。这种在细胞内达到高浓度的能力可能是伊曲康唑体内疗效的一项重要特性。
相似文献
1
Uptake of itraconazole by alveolar macrophages.伊曲康唑在肺泡巨噬细胞中的摄取。
Antimicrob Agents Chemother. 1993 Apr;37(4):903-4. doi: 10.1128/AAC.37.4.903.
2
Pharmacokinetics of oral antifungals and their clinical implications.口服抗真菌药物的药代动力学及其临床意义。
Br J Clin Pract Suppl. 1990 Sep;71:50-6.
3
The triazole antifungal agents: a review of itraconazole and fluconazole.三唑类抗真菌药物：伊曲康唑和氟康唑综述
Pharmacotherapy. 1990;10(2):146-53.
4
The clinical pharmacokinetics of itraconazole: an overview.伊曲康唑的临床药代动力学：综述
Mycoses. 1989;32 Suppl 1:67-87. doi: 10.1111/j.1439-0507.1989.tb02296.x.
5
Itraconazole concentrations in airway fluid and tissue.气道分泌物和组织中的伊曲康唑浓度。
Br J Clin Pharmacol. 1992 Feb;33(2):206-7. doi: 10.1111/j.1365-2125.1992.tb04030.x.
6
Itraconazole therapy for nonmeningeal coccidioidomycosis: clinical and laboratory observations.伊曲康唑治疗非脑膜球孢子菌病：临床及实验室观察
J Am Acad Dermatol. 1990 Sep;23(3 Pt 2):593-601. doi: 10.1016/0190-9622(90)70261-f.
7
Itraconazole.
Med Lett Drugs Ther. 1993 Jan 22;35(888):7-9.
8
Effect of amphotericin B, fluconazole and itraconazole on intracellular Candida albicans and germ tube development in macrophages.两性霉素B、氟康唑和伊曲康唑对巨噬细胞内白色念珠菌及芽管发育的影响
J Antimicrob Chemother. 1990 May;25(5):803-11. doi: 10.1093/jac/25.5.803.
9
Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses.伊曲康唑。对其药效学和药代动力学特性以及在浅表和全身性真菌病治疗中的应用进行综述。
Drugs. 1989 Mar;37(3):310-44. doi: 10.2165/00003495-198937030-00003.
10
Role of animal and human pharmacology in antifungal drug design.动物和人体药理学在抗真菌药物设计中的作用。
Ann N Y Acad Sci. 1988;544:264-9. doi: 10.1111/j.1749-6632.1988.tb40412.x.
引用本文的文献
1
Potency and Preclinical Evidence of Synergy of Oral Azole Drugs and Miltefosine in an Model of () Infection.唑类口服药物与米替福新联合治疗 () 感染模型的效价和临床前证据。
Antimicrob Agents Chemother. 2022 Jan 18;66(1):e0142521. doi: 10.1128/AAC.01425-21. Epub 2021 Oct 25.
2
A Combination of Itraconazole and Amiodarone Is Highly Effective against Infection of Human Stem Cell-Derived Cardiomyocytes.伊曲康唑和胺碘酮联合治疗对人干细胞源性心肌细胞感染具有高度疗效。
Am J Trop Med Hyg. 2019 Aug;101(2):383-391. doi: 10.4269/ajtmh.19-0023.
3
Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.抗真菌药物的药代动力学：优化患者治疗的实际意义。
Infection. 2017 Dec;45(6):737-779. doi: 10.1007/s15010-017-1042-z. Epub 2017 Jul 12.
4
High Intracellular Concentrations of Posaconazole Do Not Impact on Functional Capacities of Human Polymorphonuclear Neutrophils and Monocyte-Derived Macrophages In Vitro.泊沙康唑的高细胞内浓度对人多形核中性粒细胞和单核细胞衍生巨噬细胞的体外功能能力没有影响。
Antimicrob Agents Chemother. 2016 May 23;60(6):3533-9. doi: 10.1128/AAC.02060-15. Print 2016 Jun.
5
Tissue penetration of antifungal agents.抗真菌药物的组织穿透性。
Clin Microbiol Rev. 2014 Jan;27(1):68-88. doi: 10.1128/CMR.00046-13.
6
A case report of chronic granulomatous disease presenting with aspergillus pneumonia in a 2-month old girl.
Korean J Pediatr. 2010 Jun;53(6):722-6. doi: 10.3345/kjp.2010.53.6.722. Epub 2010 Jun 23.
7
Intracellular concentrations of posaconazole in different compartments of peripheral blood.泊沙康唑在不同外周血隔室中的细胞内浓度。
Antimicrob Agents Chemother. 2010 Jul;54(7):2928-31. doi: 10.1128/AAC.01407-09. Epub 2010 May 10.
8
Pharmacokinetics/pharmacodynamics of echinocandins.棘白菌素类的药代动力学/药效学
Eur J Clin Microbiol Infect Dis. 2004 Nov;23(11):805-12. doi: 10.1007/s10096-004-1228-z. Epub 2004 Oct 14.
9
Intrapulmonary pharmacokinetics and pharmacodynamics of itraconazole and 14-hydroxyitraconazole at steady state.稳态下伊曲康唑和14-羟基伊曲康唑的肺内药代动力学和药效学
Antimicrob Agents Chemother. 2004 Oct;48(10):3823-7. doi: 10.1128/AAC.48.10.3823-3827.2004.
10
Antifungal resistance trends towards the year 2000. Implications for therapy and new approaches.2000年抗真菌耐药性趋势。对治疗的影响及新方法
Drugs. 1997 Nov;54(5):657-78. doi: 10.2165/00003495-199754050-00002.
本文引用的文献
1
Antibiotic uptake by alveolar macrophages.肺泡巨噬细胞对抗生素的摄取。
J Lab Clin Med. 1980 Mar;95(3):429-39.
2
Membrane transport of clindamycin in alveolar macrophages.克林霉素在肺泡巨噬细胞中的膜转运
Antimicrob Agents Chemother. 1982 Feb;21(2):241-7. doi: 10.1128/AAC.21.2.241.
3
R 51211 (itraconazole) therapy of murine cryptococcosis.R 51211（伊曲康唑）对小鼠隐球菌病的治疗
Sabouraudia. 1984;22(6):445-53. doi: 10.1080/00362178485380721.
4
Effects of antifungal agents and gamma interferon on macrophage cytotoxicity for fungi and tumor cells.抗真菌剂和γ干扰素对巨噬细胞针对真菌和肿瘤细胞的细胞毒性的影响。
J Infect Dis. 1987 Aug;156(2):316-23. doi: 10.1093/infdis/156.2.316.
5
Itraconazole for cryptococcal infection in the acquired immunodeficiency syndrome.伊曲康唑用于获得性免疫缺陷综合征中的隐球菌感染。
Ann Intern Med. 1987 Jan;106(1):166. doi: 10.7326/0003-4819-106-1-166_1.
6
Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits.伊曲康唑与氟康唑治疗兔隐球菌性脑膜炎和念珠菌性肾盂肾炎的比较。
Antimicrob Agents Chemother. 1986 Apr;29(4):579-83. doi: 10.1128/AAC.29.4.579.
7
Itraconazole therapy for cryptococcal meningitis and cryptococcosis.伊曲康唑治疗隐球菌性脑膜炎和隐球菌病。
Arch Intern Med. 1989 Oct;149(10):2301-8.
8
Experience with itraconazole in cryptococcosis and aspergillosis.伊曲康唑治疗隐球菌病和曲霉病的经验。
J Infect. 1989 Mar;18(2):151-65. doi: 10.1016/s0163-4453(89)91178-x.
Zotero 插件